Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells

Neuropeptides

Volumn 41, Issue 6, 2007, Pages 441-452

  Zagon, Ian S ^a   Rahn, Kristen A ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion; Chemotaxis; Colon adenocarcinoma; Head and neck squamous cell carcinoma; In vitro; Invasion; Migration; Neoplasia; Pancreatic adenocarcinoma

Indexed keywords

BETA ENDORPHIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DELTA OPIATE RECEPTOR; DYNORPHIN[1-8]; ENDOMORPHIN 1; FIBRONECTIN; KAPPA OPIATE RECEPTOR; LAMININ; METENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTREXONE; OPIATE; VITRONECTIN;

ARTICLE; CANCER CELL; CELL ADHESION; CELL DIVISION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHEMOTAXIS; COLON CANCER; CONTROLLED STUDY; CYTOLOGY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PHYSIOLOGY; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, METHIONINE; HUMANS; MEMBRANE GLYCOPROTEINS; NALTREXONE; NARCOTIC ANTAGONISTS; NEOPLASM INVASIVENESS; NEOPLASMS; OPIOID PEPTIDES;

AGOUTI PACA;

EID: 36048954445     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.08.002     Document Type: Article

References (44)

1. Bisignani G.J., McLaughlin P.J., Ordille S.D., Beltz M.S., Jarowenko M.V., and Zagon I.S. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor. J. Urol. 162 (1999) 2186-2191
2. Blebea J., Mazo J.E., Kihara T.K., Vu J.-H., McLaughlin P.J., Atnip R.G., and Zagon I.S. Opioid growth factor modulates angiogenesis. J. Vascular Surg. 32 (2000) 364-373
3. Cheng, F., Zagon, I.S., Verderame, M.F., McLaughlin, P.J., in press. The OGF-OGFr axis utilizes the p16 pathway to inhibit progression of human squamous cell carcinoma of the head and neck. Cancer Res.
4. El-Hage N., Wu G., Wang J., Ambati J., Knapp P.E., Reed J.L., Bruce-Keller A.J., and Hauser K.F. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53 (2006) 132-146
5. Gioanni J., Fischel J.-L., Lambert J.-C., Demard F., Mazeau C., Zanghellini E., Ettore F., Formento P., Chauvet P., Lalanne C.-M., and Courdi A. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol. 24 (1988) 1445-1455
6. Gutstein H.B., and Akil H. Opioid analgesics. In: Hartman J.G., and Limbird L.E. (Eds). The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 69-619
7. Harimaya Y., Koizumi K., Andoh T., Nojima H., Kuraishi Y., and Saiki I. Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett. 187 (2002) 121-127
8. Heagy W., Duca K., and Finberg R.W. Enkephalins stimulate leukemia cell migration and surface expression of CD9. J. Clin. Invest. 96 (1995) 1366-1374
9. Hu S., Chao C.C., Hegg C.C., Thayer S., and Peterson P.K. Morphine inhibits human microglial production of, and migration towards, RANTES. J. Pyschopharmacol. 14 (2000) 238-243
10. Hytrek S.D., Smith J.P., McGarrity T.J., McLaughlin P.J., Lang C.M., and Zagon I.S. Identification and characterization of ζ-opioid receptor in human colon cancer. Amer. J. Physiol. 271 (1996) R115-R121
11. Klocek M.S., Sassani J.S., McLaughlin P.J., and Zagon I.S. Topically applied naltrexone restores corneal reepithelialization in diabetic rats. J. Ocular Pharmacol. Therap. 23 (2007) 89-102
12. Krause C.J., Carey T.E., Ott R.W., Hrubis C., McClatchey K.D., and Regezi J.A. Human squamous cell carcinoma. Arch. Otolaryngol. 107 (1981) 703-710
13. Leslie F.M. Methods used for the study of opioid receptors. Pharmacol. Rev. 39 (1987) 197-249
14. McLaughlin P.J., Levin R.J., and Zagon I.S. Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int. J. Oncol. 14 (1999) 991-998
15. McLaughlin P.J., Levin R.J., and Zagon I.S. The opioid growth factor receptor in human head and neck squamous cell carcinoma. Int. J. Mol. Med. 5 (2000) 191-196
16. McLaughlin P.J., Verderame M.F., Hankins J., and Zagon I.S. Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck. Int. J. Mol. Med. 19 (2007) 421-428
17. McLaughlin P.J., Zagon I.S., and Skitzki J. Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor. Int. J. Oncol. 14 (1999) 373-380
18. McLaughlin P.J., and Zagon I.S. Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor (OGFr). Int. J. Oncol. 28 (2006) 1577-1583
19. Miyagi T., Chuang L.F., Lam K.M., Kung H.-F., Wang J.M., Osburn B.I., and Chuang R.Y. Opioids suprress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. Immunopharmacol. 47 (2000) 53-62
20. Nagakawa O., Ogasawara M., Fujii H., Murakami K., Murata J., and Saiki Fuse H. Effects of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Lett. 133 (1998) 27-33
21. 1 integrin-mediated monocyte adhesion. J. Immunol. 176 (2006) 1675-1685
22. Ruff M.R., Wahl S.M., Mergenhagen S., and Pert C.B. Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides 5 (1985) 363-366
23. Sibinga N.E.S., and Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6 (1988) 219-249
24. Singhal P.C., Abramovici M., Bansal M., Jaffer S., Mattana J., Shah R., and Gibbons N. Opioids modulate migration, spreading and adherence of mesangial cells. Nephron 68 (1994) 366-371
25. Szabo I., Wetzel M.A., and Rogers T.J. Cell-density-regulated chemotactic responsiveness of keratinocytes in vitro. J. Invest. Dermatol. 117 (2001) 1083-1090
26. Takayama N., and Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J. Neurosci. 25 (2005) 430-435
27. Zagon I.S., Hytrek S.D., and McLaughlin P.J. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Amer. J. Physiol. 271 (1996) R511-R518
28. Zagon I.S., Hytrek S.D., Smith J.P., and McLaughlin P.J. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. Cancer Lett. 112 (1997) 167-175
29. Zagon I.S., and McLaughlin P.J. Naltrexone modulates tumor response in mice with neuroblastoma. Science 221 (1983) 671-673
30. Zagon I.S., and McLaughlin P.J. Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancer. Life Sci. 35 (1984) 409-416
31. Zagon I.S., and McLaughlin P.J. Opioid growth factor receptor in the developing nervous system. In: Zagon I.S., and McLaughlin P.J. (Eds). Receptors in the Developing Nervous System. Growth Factors and Hormones vol. 1 (1993), Chapman & Hall, London 39-62
32. 5]-enkephalin, and the etiology, pathogenesis, and treatment of gastrointestinal cancer. In: Plotnikoff N.P., Faith R.E., Murgo A.J., and Good R.A. (Eds). Cytokines-Stress and Immunity (1999), CRC Press, Boca Raton, FL 245-260
33. Zagon I.S., and McLaughlin P.J. Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37 (2003) 79-88
34. Zagon I.S., and McLaughlin P.J. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. Int. J. Oncol. 24 (2004) 1443-1448
35. Zagon I.S., and McLaughlin P.J. Opioids and differentiation in human cancer cells. Neuropeptides 39 (2005) 495-505
36. Zagon I.S., Roesener C.D., Verderame M.F., Ohlsson-Wilhelm B.M., Levin R.J., and McLaughlin P.J. Opioid growth factor regulates the cell cycle of human neoplasias. Int. J. Oncol. 17 (2000) 1053-1061
37. Zagon I.S., Sassani J.W., Malefyt K.J., and McLaughlin P.J. Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA. Arch. Ophthalmol. 124 (2006) 1620-1624
38. Zagon I.S., Sassani J.W., and McLaughlin P.J. Opioid growth factor modulates corneal epithelial growth in tissue culture. Amer. J. Physiol. 268 (1995) R942-R950
39. Zagon I.S., Sassani J.W., and McLaughlin P.J. Reepithelialization of the human cornea is regulated by endogenous opioids. Invest. Ophthalmol. Vis. Sci. 41 (2000) 73-81
40. Zagon I.S., Smith J.P., Conter R., and McLaughlin P.J. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. Int. J. Mol. Med. 5 (2000) 77-84
41. Zagon I.S., Smith J.P., and McLaughlin P.J. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int. J. Oncol. 14 (1999) 577-584
42. Zagon I.S., Verderame M.F., Hankins J., and McLaughlin P.J. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer. Int. J. Oncol. 30 (2007) 775-783
43. Zagon I.S., Verderame M.F., and McLaughlin P.J. The biology of the opioid growth factor (OGFr). Brain Res. Rev. 38 (2002) 351-376
44. Zagon I.S., Wu Y., and McLaughlin P.J. Opioid growth factor and organ development in rat and human embryos. Brain Res. 839 (2000) 313-322